Sponsors (40)
The bill clarifies and speeds FDA’s handling of nonclinical versus clinical data—giving regulators and sponsors quicker, less ambiguous rules—but it does so by shortening public comment time and imposing modest short-term compliance and transitional burdens.
Hospitals, health systems, drug and biologic sponsors, and FDA reviewers will have clearer, statutory definitions separating nonclinical from clinical data, reducing ambiguity in reviews and helping speed regulatory decision-making.
Federal regulators and industry will see faster implementation of the clarified rule because the interim final rule is made immediately effective, shortening the timeline to regulatory clarity.
Patients, clinicians, and industry stakeholders will have reduced opportunity for input because making the interim final rule immediately effective limits public notice-and-comment time.
Hospitals, health systems and product sponsors may incur short-term compliance costs to update submissions, policies, and procedures to align with the new CFR language.
Federal employees, contractors, and legal/administrative users may face transitional confusion because renumbering statutory subsections (e.g., z to aa) will require updating references in guidance, contracts, and materials.
Based on analysis of 2 sections of legislative text.
Directs FDA to publish an interim final rule within one year updating CFR language to add and use the statutory definition of "nonclinical test," replacing generic/animal references, and makes it immediately effective.
Requires the HHS Secretary (through the FDA Commissioner) to issue an interim final rule within one year that updates FDA regulations to use and define the statutory term "nonclinical test" in place of generic or animal-specific references in key drug and biological product regulations, and makes that rule immediately effective upon publication. Also sets the act's short title and renames an existing statutory subsection relating to clinical trial diversity action plans.
Introduced April 10, 2025 by Buddy Carter · Last progress April 10, 2025